CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer

MLA

Kowalska, Kinga Hińcza-Nowak, et al. “CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.” International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10019, June 2023. EBSCOhost, https://doi.org/10.3390/ijms241210019.

APA

Kowalska, K. H.-N., Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior-Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, & Aldona. (2023). CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10019. https://doi.org/10.3390/ijms241210019

Chicago

Kowalska, Kinga Hińcza-Nowak, Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior-Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, and Aldona. 2023. “CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.” International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10019, June. doi:10.3390/ijms241210019.